NCT05796440 - A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

March 31, 2028

Study Completion Date

April 30, 2028

Conditions

Growth Hormone Deficiency

Interventions

DRUG

LUM-201

Administered orally once daily

Trial Locations (7)

Canberra Hospital, Garran

University of South Carolina, Charleston

University of Iowa, Iowa City

Children's Mercy Hospital, Kansas City

Texas Tech University Health Sciences Center, Amarillo

Seattle Children's Hospital, Seattle

UMass Memorial Medical Center, Worcester